About Us

---

CMD Ultrasound was founded in 2002 with a straightforward but uncommon idea: bring high-quality diagnostic imaging to the patient—rather than forcing the patient into a complex, expensive, and time-consuming system.

From the beginning, CMD was built as a mobile diagnostic imaging company, designed to meet patients and providers where care actually happens—clinics, workplaces, community events, and local facilities—across a broad service area. Over time, CMD’s operational footprint grew to cover a 300-mile radius across Arizona, Nevada, and Utah, making the company a regional access solution rather than a single-location clinic.

CMD’s early identity was shaped by a blend of clinical skill and field practicality: the work demanded consistent imaging quality, efficient logistics, professional communication with ordering clinicians, and a strong grasp of patient experience—often in environments that were not traditional imaging centers.

CMD’s community role has always been driven by a major healthcare reality: diagnostics are often the bottleneck. People delay imaging because of:

• scheduling delays,
   
• travel distance,
   
• cost uncertainty,
   
• confusion about what they need,
   
• and the friction of large systems.
   

CMD addressed that bottleneck by designing an operating model that prioritizes:

• speed and convenience,
   
• affordable direct-to-public options, and
   
• high-volume community availability through health fairs and local partnerships.
   

That structure makes CMD different: the company is not built like a typical imaging center competing on location and insurance contracts—it is built like a diagnostic deployment unit.

CMD offers a broad range of diagnostic and screening services that are commonly fragmented across multiple providers. Your stated service lines include:

Ultrasound (broad scope)

• Vascular
   
• Abdominal
   
• Thyroid
   
• Cardiac-focused ultrasound offerings (where applicable)
   
• Reproductive
   
• Soft tissue
   
• Additional ultrasound categories as deployed in the field
   

Cardiometabolic and health screening add-ons

• 12–15 lead EKG
   
• lipid panels
   
• A1c / glucose testing
   
• hemoglobin / hematocrit
   
• urinalysis
   

This variety matters because it allows CMD to serve the community in a way that is:

• diagnostically meaningful (not “one-size-fits-all” screening),
   
• integrated across body systems, and
   
• deployable in community settings.
   

CMD has become known in the community through direct public outreach, especially health fairs and local events. These events do more than market a service—they reduce barriers for people who:

• haven’t seen a doctor in years,
   
• are worried about cost,
   
• don’t understand what to ask for,
   
• or have risk factors but no clear next step.
   

By showing up in public venues and offering practical diagnostic access, CMD has effectively served as a community bridge between prevention and clinical care.

A defining accomplishment is that CMD has successfully collaborated with 70+ doctors. That number reflects something operationally difficult: sustained relationships with physicians require reliability, consistent quality, and professional credibility.

Most “screening” businesses remain outside the physician ecosystem. CMD’s model is different: it is designed to support physicians with:

• imaging access,
   
• expanded diagnostic reach,
   
• better patient follow-through,
   
• and reduced friction for timely evaluations.
   

This positioning allows CMD to function as an extension of a physician’s diagnostic capability, rather than merely a consumer screening vendor.

A key evolution has been CMD’s expansion into Las Vegas, specifically to increase visibility and impact. This expansion represents an intentional shift:

• from being highly capable and widely deployed,
   
• to building brand awareness and strategic community presence in a major metro market.
   

This matters because CMD has long competed against national brands that often win on name recognition rather than service quality. Entering Las Vegas is not just geographic growth—it is a move toward:

• stronger partnerships,
   
• higher patient volume,
   
• and a more scalable platform for outreach.
   

CMD’s accomplishments are not “hype”—they are operational and community-based:

1. Founded and sustained since 2002 in a medically demanding field
    
2. Mobile diagnostic model deployed across a multi-state region (300-mile service radius)
    
3. Comprehensive direct-to-public diagnostic services, beyond a single screening modality
    
4. Health fair leadership and community deployment, improving access and early detection
    
5. Ongoing collaboration with 70+ physicians, demonstrating professional trust and continuity
    
6. Strategic expansion into Las Vegas to scale visibility, partnerships, and community impact
    

Many national competitors sell simplified “screening packages.” CMD’s identity is fundamentally different: it is built around diagnostic capability, not just consumer marketing.

Traditional imaging is location-bound. CMD is mobile and operationally engineered to deliver diagnostic services across clinics, events, and community sites—without sacrificing professionalism.

Most providers either offer:

• broad medical capability inside a costly system, or
   
• cheap screening with limited scope.
   

CMD is positioned between those extremes: broad offerings with accessible delivery.

CMD’s trust is built through:

• showing up locally,
   
• serving real people,
   
• and developing local clinical relationships.
   

That produces a different kind of reputation than national brands that rely on mass marketing and standardized scripts.

Because CMD already blends imaging, cardiometabolic screening, and physician collaboration, it is positioned to become a diagnostic gateway for broader prevention and longitudinal health programs.

CMD Ultrasound operates at the intersection of advanced biomedical science, diagnostic intelligence, clinical education, and healthcare strategy. While CMD is widely recognized for its diagnostic and screening capabilities, the company’s work extends well beyond imaging alone.

At its core, CMD’s mission is focused on early disease discovery, system-level health restoration, performance optimization, and informed prevention—helping patients and medical professionals understand what is happening upstream, before disease becomes irreversible.

CMD’s work is grounded in a deep, mechanism-driven understanding of human biology, physiology, and pathophysiology. Areas of ongoing study and application include mitochondrial function, NAD⁺ metabolism, redox biology, and the signaling pathways that regulate cellular repair, energy balance, and aging—such as AMPK, mTOR, autophagy, and mitophagy.

CMD also examines inflammation, immune dysregulation, and autoimmunity as root contributors to chronic disease, alongside circadian rhythm science, sleep biology, neuroplasticity, and cognitive health.

Rather than focusing solely on symptom management, CMD emphasizes upstream intervention and risk identification across a wide range of systems, including liver, kidney, gut, thyroid, metabolic, vascular, and cardiovascular health. This includes applied study of sudden cardiac death risk, metabolic syndrome, insulin resistance, fat loss physiology, and emerging longevity science related to age deceleration and regenerative pathways.

CMD also explores cancer biology from a systems and metabolic perspective, with an emphasis on education and early risk awareness.

CMD provides non-prescriptive education and consultation related to hormonal physiology and emerging regenerative strategies. This includes testosterone, estrogen, thyroid, and androgen-related science; peptide education frameworks; PRP, IV, injection, and shockwave therapy concepts; and men’s and women’s sexual health topics such as libido, erectile dysfunction, and prostate health.

CMD also studies supplementation timing, stacking, and protocol design as part of broader metabolic and hormonal optimization strategies.

Drawing on extensive background in respiratory therapy and cardiopulmonary medicine, CMD integrates pulmonary science with neurological and performance-based health concepts. This includes pain science, back pain mechanisms, neuromuscular recovery, cognitive performance strategies, and applied neurobiology related to mood, PTSD, and depression.

CMD incorporates modern assessment tools to enhance insight and efficiency, including AI-assisted bloodwork interpretation, biomarker-driven analysis, systems-based risk stratification, and optimization modeling. These tools support clearer communication, better patient education, and more informed collaboration with physicians.

CMD actively examines healthcare systems, policy incentives, regulatory constraints, and the real-world economics of medical practice. This includes physician education, practice sustainability, revenue diversification, and strategic deployment of diagnostic and preventive services.

CMD extends its impact through professional education, public speaking, partnerships, and ecosystem building. The company also engages in digital health communication through video, social media, and educational content designed to translate complex medical science into understandable, actionable insight.